Epidemiological and clinical profiles of Saudi patients with hyperprolactinemia in a single tertiary care center

BACKGROUND: Prolactin is a hormone of the pituitary gland whose main function is the production of milk. Hyperprolactinemia is defined as an increase in prolactin levels above 25 μg/L in women and 20 μg/L in men. Causes of hyperprolactinemia include pituitary tumors, especially prolactinomas. Hyperp...

Full description

Bibliographic Details
Main Authors: Moeber Mahzari, Khalid Saad Alhamlan, Nawaf Abdulaziz Alhussaini, Turki Abdullah Alkathiri, Abdulmohsen Nasser Al Khatir, Abdulaziz Mohammed Alqahtani, Emad Fayez Masuadi
Format: Article
Language:English
Published: King Faisal Specialist Hospital and Research Centre 2022-09-01
Series:Annals of Saudi Medicine
Online Access:http://www.annsaudimed.net/doi/10.5144/0256-4947.2022.334
_version_ 1811240860856090624
author Moeber Mahzari
Khalid Saad Alhamlan
Nawaf Abdulaziz Alhussaini
Turki Abdullah Alkathiri
Abdulmohsen Nasser Al Khatir
Abdulaziz Mohammed Alqahtani
Emad Fayez Masuadi
author_facet Moeber Mahzari
Khalid Saad Alhamlan
Nawaf Abdulaziz Alhussaini
Turki Abdullah Alkathiri
Abdulmohsen Nasser Al Khatir
Abdulaziz Mohammed Alqahtani
Emad Fayez Masuadi
author_sort Moeber Mahzari
collection DOAJ
description BACKGROUND: Prolactin is a hormone of the pituitary gland whose main function is the production of milk. Hyperprolactinemia is defined as an increase in prolactin levels above 25 μg/L in women and 20 μg/L in men. Causes of hyperprolactinemia include pituitary tumors, especially prolactinomas. Hyperprolactinemia can manifest clinically with a variety of symptoms, including galactorrhea and menstrual irregularities in women and erectile dysfunction in men. There are limited data on the epidemiology of hyperprolactinemia in the Middle East region. OBJECTIVES: Description of the epidemiology and clinical features of hyperprolactinemia in a cohort from Saudi Arabia. DESIGN: Medical record review SETTING: Tertiary medical center in Riyadh PATIENTS AND METHODS: The study included adult patients with hyperprolactinemia in King Abdulaziz Medical City in Riyadh. The patients were treated in endocrinology clinics from 2015 to 2019. Patients of both sexes older than 14 years were enrolled in the study. Patients with insufficient follow-up were excluded. Data were collected on demographic characteristics, symptoms, prolactin level, cause of high prolactin level, and treatment. MAIN OUTCOME MEASURES: The frequency of different etiologies and symptoms in patients with hyperprolactinemia. SAMPLE SIZE: 295 patients RESULTS: The majority of patients with hyperprolactinemia were female 256 (86.8%). Hyperprolactinemia was diagnosed more frequently in patients in the age groups 21–30 years (42.6%) and 31–40 years (24.1%). The majority of the study population was obese or overweight: 136 (46.3%) and 74 (25.2%), respectively. Most of the cases were symptomatic (192, 65.1%). In women, the most common symptom was oligomenorrhea (35%). In men, infertility and erectile dysfunction were the most common clinical symptoms (50% and 44.7%, respectively). Idiopathic causes were the most common etiology (108, 36.6%), followed by pituitary adenomas (81, 27.5%). The majority of patients were treated (184,62.4%), with cabergoline being the most commonly used medication (173, 94.0%). CONCLUSION: The demographic and clinical presentations and causes of hyperprolactinemia in male and female Saudi patients were similar to that in studies in other populations. LIMITATIONS: Single-center retrospective chart review study. CONFLICT OF INTEREST: None.
first_indexed 2024-04-12T13:27:19Z
format Article
id doaj.art-72f8a2a83b5841d8874c71c80e1bc5bb
institution Directory Open Access Journal
issn 0256-4947
0975-4466
language English
last_indexed 2024-04-12T13:27:19Z
publishDate 2022-09-01
publisher King Faisal Specialist Hospital and Research Centre
record_format Article
series Annals of Saudi Medicine
spelling doaj.art-72f8a2a83b5841d8874c71c80e1bc5bb2022-12-22T03:31:17ZengKing Faisal Specialist Hospital and Research CentreAnnals of Saudi Medicine0256-49470975-44662022-09-0142533434210.5144/0256-4947.2022.334Epidemiological and clinical profiles of Saudi patients with hyperprolactinemia in a single tertiary care centerMoeber Mahzari0Khalid Saad Alhamlan1Nawaf Abdulaziz Alhussaini2Turki Abdullah Alkathiri3Abdulmohsen Nasser Al Khatir4Abdulaziz Mohammed Alqahtani5Emad Fayez Masuadi6From the College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaFrom the College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaFrom the College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaFrom the College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaFrom the College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaFrom the College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaFrom the College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaBACKGROUND: Prolactin is a hormone of the pituitary gland whose main function is the production of milk. Hyperprolactinemia is defined as an increase in prolactin levels above 25 μg/L in women and 20 μg/L in men. Causes of hyperprolactinemia include pituitary tumors, especially prolactinomas. Hyperprolactinemia can manifest clinically with a variety of symptoms, including galactorrhea and menstrual irregularities in women and erectile dysfunction in men. There are limited data on the epidemiology of hyperprolactinemia in the Middle East region. OBJECTIVES: Description of the epidemiology and clinical features of hyperprolactinemia in a cohort from Saudi Arabia. DESIGN: Medical record review SETTING: Tertiary medical center in Riyadh PATIENTS AND METHODS: The study included adult patients with hyperprolactinemia in King Abdulaziz Medical City in Riyadh. The patients were treated in endocrinology clinics from 2015 to 2019. Patients of both sexes older than 14 years were enrolled in the study. Patients with insufficient follow-up were excluded. Data were collected on demographic characteristics, symptoms, prolactin level, cause of high prolactin level, and treatment. MAIN OUTCOME MEASURES: The frequency of different etiologies and symptoms in patients with hyperprolactinemia. SAMPLE SIZE: 295 patients RESULTS: The majority of patients with hyperprolactinemia were female 256 (86.8%). Hyperprolactinemia was diagnosed more frequently in patients in the age groups 21–30 years (42.6%) and 31–40 years (24.1%). The majority of the study population was obese or overweight: 136 (46.3%) and 74 (25.2%), respectively. Most of the cases were symptomatic (192, 65.1%). In women, the most common symptom was oligomenorrhea (35%). In men, infertility and erectile dysfunction were the most common clinical symptoms (50% and 44.7%, respectively). Idiopathic causes were the most common etiology (108, 36.6%), followed by pituitary adenomas (81, 27.5%). The majority of patients were treated (184,62.4%), with cabergoline being the most commonly used medication (173, 94.0%). CONCLUSION: The demographic and clinical presentations and causes of hyperprolactinemia in male and female Saudi patients were similar to that in studies in other populations. LIMITATIONS: Single-center retrospective chart review study. CONFLICT OF INTEREST: None.http://www.annsaudimed.net/doi/10.5144/0256-4947.2022.334
spellingShingle Moeber Mahzari
Khalid Saad Alhamlan
Nawaf Abdulaziz Alhussaini
Turki Abdullah Alkathiri
Abdulmohsen Nasser Al Khatir
Abdulaziz Mohammed Alqahtani
Emad Fayez Masuadi
Epidemiological and clinical profiles of Saudi patients with hyperprolactinemia in a single tertiary care center
Annals of Saudi Medicine
title Epidemiological and clinical profiles of Saudi patients with hyperprolactinemia in a single tertiary care center
title_full Epidemiological and clinical profiles of Saudi patients with hyperprolactinemia in a single tertiary care center
title_fullStr Epidemiological and clinical profiles of Saudi patients with hyperprolactinemia in a single tertiary care center
title_full_unstemmed Epidemiological and clinical profiles of Saudi patients with hyperprolactinemia in a single tertiary care center
title_short Epidemiological and clinical profiles of Saudi patients with hyperprolactinemia in a single tertiary care center
title_sort epidemiological and clinical profiles of saudi patients with hyperprolactinemia in a single tertiary care center
url http://www.annsaudimed.net/doi/10.5144/0256-4947.2022.334
work_keys_str_mv AT moebermahzari epidemiologicalandclinicalprofilesofsaudipatientswithhyperprolactinemiainasingletertiarycarecenter
AT khalidsaadalhamlan epidemiologicalandclinicalprofilesofsaudipatientswithhyperprolactinemiainasingletertiarycarecenter
AT nawafabdulazizalhussaini epidemiologicalandclinicalprofilesofsaudipatientswithhyperprolactinemiainasingletertiarycarecenter
AT turkiabdullahalkathiri epidemiologicalandclinicalprofilesofsaudipatientswithhyperprolactinemiainasingletertiarycarecenter
AT abdulmohsennasseralkhatir epidemiologicalandclinicalprofilesofsaudipatientswithhyperprolactinemiainasingletertiarycarecenter
AT abdulazizmohammedalqahtani epidemiologicalandclinicalprofilesofsaudipatientswithhyperprolactinemiainasingletertiarycarecenter
AT emadfayezmasuadi epidemiologicalandclinicalprofilesofsaudipatientswithhyperprolactinemiainasingletertiarycarecenter